SRZN Surrozen, Inc.
Healthcare$26.37-2.66%ClosedMarket Cap: $197.2M
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
-1.04
P/S
26.31
EV/EBITDA
-0.94
DCF Value
$11.37
FCF Yield
-17.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
99.1%
Operating Margin
-573.8%
Net Margin
-4571.1%
ROE
309.8%
ROA
-283.8%
ROIC
-38.0%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $5.0M | 98.7% | $-10.5M | $-127.5M | $— | — |
| Q4 null | $528.0K | 100.0% | $-12.6M | $-183.2M | $— | — |
| FY null | $3.5M | 84.6% | $-42.1M | $-242.0M | $— | — |
| Q3 null | $983.0K | 100.0% | $-10.9M | $-71.6M | $— | — |
| Q2 null | $983.0K | 100.0% | $-9.0M | $39.7M | $— | — |
| Q1 null | $983.0K | 100.0% | $-9.6M | $-27.0M | $— | — |
| Q4 null | $655.0K | 100.0% | $-8.6M | $-28.0M | $— | — |
| FY null | $10.7M | 100.0% | $-25.5M | $-63.6M | $— | — |
| Q3 null | $10.0M | 100.0% | $1.2M | $-1.4M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-9.0M | $-25.3M | $— | — |
| Q1 null | $0.00 | NaN% | $-9.1M | $-8.8M | $— | — |
| Q4 2023 | $0.00 | NaN% | $-9.7M | $-8.9M | $-4.32 | — |